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Developmental Expression of PDGF, TGF-a, and
TGF-j Genes in Preimplantation Mouse Embryos
DANIEL A. RAPPOLEE,* CAROL A. BRENNER, RICHARD SCHULTZ,t
DAVID MARK, ZENA WERB
Control of growth and differentiation during mammalian embryogenesis may be
regulated by growth factors from embryonic or maternal sources. With the use of
single-cell messenger RNA phenotyping, the simultaneous expression ofgrowth factor
transcripts in single or small numbers of preimplantation mouse embryos was
examined. Transcripts for platelet-derived growth factor A chain (PDGF-A), trans-
forming growth factor (TGF)-a, and TGF- 1, but not for four other growth factors,
were found in whole blastocysts. TGF-cx, TGF-(31, and PDGF antigens were detected
in blastocysts by immunocytochemistry. Both PDGF-A and TGF-a were detected as
maternal transcripts in the unferilized ovulated oocyte, and again in blastocysts. TGF-
P1 transcripts appeared only after fertilization. The expression of a subset of growth
factors in mouse blastocysts suggests a role for these factors in the growth and
differentiation of early mammalian embryos.
B ECAUSE PREIMPLANTATION MOUSE
embryos grow and differentiate in
the absence of exogenous factors,
endogenous factors must sustain the embryo
during the first seven to eight cleavage divi-
sions (1). Indirect evidence indicates that
preimplantation embryos may make growth
factors. Cultured embryos from around the
time of implantation produce transforming
growth factor-like bioactivity that promotes
anchorage-independent growth (2). Terato-
carcinoma cells, which are thought to be
similar to primitive ectoderm, produce
PDGF (3), insulin-like growth factor-II
(IGF-II) (4), and three stem cell growth
factors (5). After implantation in the uterus,
mouse embryos produce the fibroblast
growth factor homolog int-2, TGF-a, TGF-
3 (6), and IGF-ll (4), but the presence of
these growth factors cannot be extrapolated
to the preimplantation embryo. Direct evi-
dence for growth factor transcripts of low
D. A. Rappolee, C. A. Brenner, R. Schultz, Z. Werb,
Laboratory of Radiobiology and Environmental Health
and Department of Anatomy, University of California,
San Francisco, CA 94143-0750.
D. Mark, Department of Molecular Biology, Cetus Cor-
poration, Emeryville, CA 94608.
copy number has been impossible to obtain
in preimplantation embryos, because thou-
sands ofembryos are required to detect even
high copy number transcripts such as his-
tone or actin by RNA blot analysis (7).
We recently developed a sensitive and
quantitative method for assaying the accu-
TGF-a+ IPDGF-AITGF-11 P-actin
mulation of mRNA transcripts in small
numbers of cells. Our procedure, single-cell
RNA phenotyping (8), can detect mRNA in
a single cell and in '10 RNA transcripts,
and resolves threefold differences in input
over two orders of magnitude. Thus, this
method overcomes the difficulties inherent
in the analysis ofgrowth factor transcripts in
early embryos. It consists of a microtech-
nique for isolation of total RNA from 1 to
100 mouse embryos, coupled with two en-
zymatic steps (9): reverse transcription (RT)
and amplification of the transcribed cDNA
in a polymerase chain reaction (PCR) (10).
The positions ofthe target sequences for the
transcripts are shown in Table 1. Fragments
were selected for inclusion of restriction
sites, identification by existing cDNA clones
by DNA blot analysis, and/or inclusion of
introns that would generate longer frag-
ments if DNA or unprocessed RNA con-
taminated the reaction. When mouse cDNA
sequences were not available, oligonucleo-
tide sequences from other species were cho-
sen to cover areas of conserved sequence
with nondegenerate amino acids on the 3'
inside ends.
We detected 3-actin RNA transcripts iso-
lated from a single mouse blastocyst by RT-
PCR; the signal became stronger when the
number of PCR cycles was increased from
30 to 60 (11). We then used RT-PCR to
detect growth factor transcripts in blasto-
cysts and determined the growth factor
mRNA phenotype of the blastocysts. Three
growth factor genes, TGF-a, TGF-(1, and
PDGF-A, were expressed in mouse blasto-
cysts (Fig. 1A). The blastocysts were uncul-
tured; thus expression was not induced by
prolonged handling ofembryos. The cDNA
C) 0 C) PDGF-A
TF-a TG-3 -actinl PDGF-:A)
_~~~~~~
M|+ BF|+ B|+ B|+GB|
IEGF IbFGF INGF IG-C
Fig. 1. Detection of mRNA transcripts in mouse blastocysts by RT-PCR. (A) Expression of three
growth factor transcripts in mouse blastocysts demonstrated by agarose gel electrophoresis of the RT-
PCR amplified reaction products obtained after 60 cydes of PCR. The PCR reaction mixtures for the
blastocysts (B) contained cDNA from the RNA of 2.2 embryo equivalents in each reaction, and the
PCR reaction mixtures for the positive controls (+) containedcDNA from 10 ng oftotal RNA (9). The
molecular size markers (M) are Hae IIl-digested 4X174 replicative form DNA. (B) Restriction enzyme
analysis of cDNA fragments generated by RT-PCR. Messenger RNA transcripts were expressed by
blastocysts incubated with the enzymes indicated in Table 1. The diagnostic fagments (arrowheads) are
TGF-a, 159 bp; TGF-,B1, 119 + 125 bp; ,-actin, 151 bp; and PDGF-A, 129 bp. (C) Lack of
expression offour growth factors in mouse blastocysts demonstrated by agarose gel electrophoresis of
the RT-PCR amplified reaction products obtained after 60 cydes ofPCR. The PCR reaction nixtr
for blastocysts (B) contained cDNA from the mRNA of 2.2 embryo equivalents in each reaction, and
the PCR reaction mixtures for the positive controls (+) contained cDNA from 10 to 100 ng of total
RNA. The threshold for detection of the growth factors is generally <1 to 100 pg of total RNA; for
NGF, as few as ten RNA molecules can be detected by RT-PCR (8).
30 SEPTEMBER I988
Escherichia coli strain in which the synthesis of IL-3
was driven by the bacteriophage A pL promoter.
The intercellularly expressed IL-3 was purified to
homogeneity by reversed-phase high-performance
liquid chromatography in the presence of urea and
dithiothreitol. The biologically active protein was
produced by dilution of the denaturant, addition of
oxidized glutathione, and dialysis against decreasing
concentrations of urea. The purified IL-3 was for-
mulated in physiological saline, and the final prepa-
ration had less than 1 U ofendotoxin per milligram
as measured by the Limulus amoebocyte lysate assay
*To whom all correspondence should be addressed.
tPresent address: Department of Biology, University of
Pennsylvania, Philadclphia, PA 19104.
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frgents genated in the PCR were iden- sic fibrobList growth factor (bFGF), nerve TGF-pl mRNA was present in oocyte, but
tical to those produced by adut nxnue grwh ato- (NGF-A), and graulocyte this traniscrpt aperdafterfetlzio
tissues known to expTess these apts olo ling factor (GCF), that are and icasd in to the blatocyst
Because oligo(dT) was used to pime the eressed in tisSue in adu me wre not stage (Fig. 2C). As a positive control, wc
RT,t sleW nally derived (Fig. 1C). used the trnscipt for th lop e
fiom Jpolyad ed [poly(A) ] RNA. The The a of growth fictr tran- stromelysin (13), i is present ough-
choice of the prieIrs da that only scriptsw PDGF-A was out preimplann em ic elop
. ense-strand RNA t wer d in un iliz ovulatd oocytes as a ment (14).
by RT-PCR Analysis of'the nen- matenal traci -tdaisaped be- Becaus niption of gow fad
zyme deavage pa;t-of the fimnts was tween the 2- and 8-cel and reap- mRNA is not invariably coupled with the
used to Confirm thei identky (Fig. IB). We peared in early cavhation blastoy (32- to translation of thiese transciptsint proMn=
also valiated the PCR by 64-ce stage) (Fig. 2A).Acording to dilu- (15), it was necy to detmine whether
DNA blot analysis witi cDNA probes (1). tLon e (11), this dmge in PDGF- these transrsnpts weretram l Wc ienti-
Because tygotic gox is A essionwu ina moretan fiedTGF-a (Fig.3A), PDG 1ig.B) and
very active by the blastocyst sae(12), it tenldbdif n ptnm es e- TGF-p1 (Fig. 3C) antigens byi
was n t ruleot the pib tat ween oocyst a l t stges. We saw cal localizaion in pmeabiized
blastocystsexprsgrowthactog s a similar epressiontten rTGF-a n- blysts (16). TIe immunofluoresnt
miscuOAsly. Howcver, four other growth scripts, begining thtde lized ovu- signal for both TGF-a and PDGF antigens
fctors, epidermal gowth factor (EGF) ba- lated oocyte (Fig. 2B).-n contrast, little was concentrated in puncte structures in
tde perinudear area of all cells ofte blasto-
:B___________7. cyst0:: .X...:C:; ;.k-¢:-S,and TGF-,1antigenwasouund in 70
-ao.-90%- of the ces; thius the cells were
_ _
; ;~~~~ ~
~~~~~~~~~~~~~~~~~~bar44 4 the, grow& factmr.
The signal was diminished byfirst incubat-
thinge antisera with purified soluble and-
_-gens, inditing that the signal was specific.
_______________ We have provided direCt evde that
E 8 B E 8B M e 16 M1E2` 4-. 1 BM TGF-ct, TGFl1, and PDGF-A genes are
Stromelysin PDGF-A TGF-a TGF1 expressed in mousc blastocysts, whereas
Fg. 2. Temporal regulation of g fact expression in the reIm nation mouse embryo. EGF, bFGF, NGF-,, and G-CSF-gcnes are
Agarose geldecophoresis dof R-PCreaction products obtained after 60 cydes ofPCR not transcribedL It is possible that TGF-ct,
,(A) PDGF-A rn e each con ed cDNA from the mRNA of the PDGF-A, and TGF-01, indvidually or in
euival tof 4.2 un lizm ovlat ), 8i-ce zygo (8), or 3.6 early cavitation combination, account for the nsfo(32-cell) blastocyss(B). woR.N i reaction was approim5ate ES, 4.7, and 5.3 ng grow fa r-likc activity descib by Riz
respectively (12). As a positive ctbontr the RT-PCR rns, we amplified fr muns ofthenlkn in, v hic is present at all theebo cs shown in m (2).t same number ofmbqr. (B) Tt - (C) TGF-1 transpt.In (B) and (C) dte PCR accumulation patters of growth fac-
mixturescntained cDNA p re4aegg (E), 8.8 2-cel zygotes (2), 5.2 4-cell tor transcipn mouseembryos into
yos (4), 2.4 16-c morule (I6), a 4.4 yss (B). In (B) 4.4 eght ebyos (8) were three classes. In one dass, ind ing PDGF-
also assayed. Migration of the alrby A and T -a, rnal tra pts a
size mark (M) am asmh X size markers-(M) are as indicated in ~ 1. ently disappeared and were resynthesized in
the zygote. This is also true for FGF (17)
ind PDGF-A (18) in Xenopus. In theFseond
cla, tra s suc as TGF-pl were not
presentmatenally but appeared as the result
'Of zygotic trcription. In the third class,
transcripts such as that for the metallopro-
teinse stro lysin aely survived the
breakdown of at mRNA that ocurs
after fetiliztion (12). The TGF-f34ikc Vgl
7 in Xepus (19) is in thethi dass, in
_contrast to TGF-p1 in mouse, which is in_ _: 0 * ai~~~~~~~~~~~~~~~~~~~~~~~tasts.
.
Mo se
-The presece of the three grwth tr
:f~~~~~~~~~~~~~~t~ouiospen etm-
_~~~~~~~~~~~~~~~~~~~~~~~rr~ Th fuctn of grwt factors can
Fig. L = be ; ~ taop (ILton mitsis or
antiTGFo,(ad)a GF- abrtcwWlaF-c {snW lslbbe cns. (8 difeetain -and dieion (within the
PDGF. (a, and sLad b, and b') Two foa anti- emibryoobryo and the
PDGF; (e and d) bla treat with n al gosew .(e and f) b ysr d with ati- rwh or action
PDGFaPDGF ang.hearrowheadinb' showsamuraltropbecpeicdl(C,)TGF- i mammalian eatl embryos implicate
p. Blas cwresid with (a and b) an -TGF-l1, (c and t) n ne rabit Iva and (e and
.f)anti-TGF- l absorbedwithTGFil antigen. The awheads in (b) sow ave lin (A), (B), f i i d aton rather than
and (C) all te panels on the kft are phase-conpy and all the panels on the a m itosis. bFGF and TGF-,8appear to beimmunoftuorscence. morphogens for ind ng meode at thei
1824 CIENCE,, YOw240
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Table 1. Oligonucleotide primers used for RNA phenotyping analysis. Sequences are from published
sources (27).
Amplified fragmnent Location of oligonucleotidesTranscriptim nucleotide sequence
Predicted Restriction 5' Oligo- 3' Oligo-
size (bp) site nucleotide nucleotide
,B-Actin, mouse 240 Bgl II 25-44 269-245
TGF-a, rat 239 Sph I 58-78 297-277
TGF-11, mouse 244 Sma I 1277-1296 1521-1502
PDGF-A, human 224 Acc I 622-645 848-826
EGF, mouse 350 Pst I 3953-3972 4200-4181
bFGF, bovine 282 Bam HI 295-321 578-554
NGF-,, mouse 422 Nco I 248-267 649-630
G-CSF, mouse 294 Pvu II 490-517 705-681
Stromelysin, rabbit 212 Nco I 1278-1297 1480-1461
blastulation stage in Xenopus (17, 19). How-
ever, early development of the mouse has
several properties that distinguish it from
that of the frog. First, the mouse egg is
small, has little yolk, and quickly activates its
zygotic transcription after fertilization (12).
Second, the mouse has 10- to 12-hour cell
cycle times after the first two cell cycles (20).
These cycles have the normal G1-S-G2-M
periods, which may allow early transcription
ofgrowth factors, as well as the opportunity
to be influenced by growth factors, in con-
trast to the early cell cycles of the frog,
which lack GI and G2 (21).
Several lines of evidence indicate that
mammalian embryonic factors are directed
at maternal tissue. TGF-a and TGF-P are
known to be angiogenic (22), and the high-
est density of uterine capillary beds is oppo-
site the implanting blastocyst (23). In addi-
tion, the uterine environment is hypoxic
(24), a condition that promotes production
of angiogenic factors by wound healing cells
(25). Finally, TGF-a is an EGF receptor-
binding ligand, and at the time of implanta-
tion there is a surge of estrogen that in-
creases EGF-receptor expression in the uter-
us severalfold (26). Thus, embryonic growth
factors may induce the early angiogenesis
and decidualization of the uterus. Whether
embryonic growth factors are directed at
intraembryonic targets will be determined
only when it is demonstrated that genes for
embryonic growth factor receptors are tran-
scribed and translated and that these recep-
tors are functional.
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